TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8383012

Group type: EXPERIMENTAL
Intervention: pH adjusted mepivacaine (4 ml sodium bicarbonate added, final pH 7.31)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (4 ml saline added, final pH 5.6)
Number of subjects: 39
Study: 3533546

Group type: EXPERIMENTAL
Intervention: Mexiletine (Mexitil‐Perlongets), 360 mg b.i.d.
Number of subjects: 630

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 630
Study: 31499515

Group type: EXPERIMENTAL
Intervention: SVHD group
Number of subjects: 25

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 25
Study: 29550362

Group type: EXPERIMENTAL
Intervention: MD with aPDT (test group)
Number of subjects: 38

Group type: COMPARATOR
Intervention: MD only (control group)
Number of subjects: 38
Study: 27707818

Group type: EXPERIMENTAL
Intervention: MAG-enriched oil (500 mg EPA/day and 300 mg DHA/day)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: MAG-enriched oil
Number of subjects: 45

Group type: COMPARATOR
Intervention: TAG
Number of subjects: 45
Study: 24949605

Group type: EXPERIMENTAL
Intervention: Single dose PMC (PMC4/0)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Single dose PEG (PEG4/0)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Split dose PMC (PMC2/2)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Split dose PEG (PEG3/1)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: PMC (any regimen)
Number of subjects: 600

Group type: COMPARATOR
Intervention: 4L PEG
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Split PMC dose
Number of subjects: 600
Study: 22337905

Group type: EXPERIMENTAL
Intervention: Dexamethasone (DEX; 1 mg)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 20167180

Group type: EXPERIMENTAL
Intervention: Insulin detemir, dosed once daily
Number of subjects: 29

Group type: COMPARATOR
Intervention: Insulin glargine, dosed once daily
Number of subjects: 29
Study: 19046729

Group type: EXPERIMENTAL
Intervention: Ceftriaxone plus ciprofloxacin
Number of subjects: 95

Group type: COMPARATOR
Intervention: Ceftazidime plus amikacin
Number of subjects: 95
Study: 15818325

Group type: EXPERIMENTAL
Intervention: Allogeneic reduced-intensity hematopoietic stem cell transplantation (RIST)
Number of subjects: 7
Study: 12578294

Group type: EXPERIMENTAL
Intervention: TPN with 1 IU ml(‐1) of heparin (n = 35)
Number of subjects: 66

Group type: COMPARATOR
Intervention: No heparin (n = 31)
Number of subjects: 66
Study: 10615932

Group type: EXPERIMENTAL
Intervention: Adjuvant radiotherapy and 5-fluorouracil
Number of subjects: 218

Group type: COMPARATOR
Intervention: Observation alone
Number of subjects: 218
Study: 8623079

Group type: EXPERIMENTAL
Intervention: Lumpectomy with radiation
Number of subjects: 4

Group type: COMPARATOR
Intervention: Lumpectomy alone
Number of subjects: 4
Study: 1747614

Group type: EXPERIMENTAL
Intervention: Intervention schools (n=228)
Number of subjects: 451

Group type: COMPARATOR
Intervention: Control schools (n=223)
Number of subjects: 451

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 451
Study: 7188378

Group type: EXPERIMENTAL
Intervention: 5.0 mg zopiclone
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 10.0 mg zopiclone
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 7.5 mg zopiclone
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 30063996

Group type: EXPERIMENTAL
Intervention: Defibrillation Testing (DT)
Number of subjects: 251

Group type: COMPARATOR
Intervention: No Defibrillation Testing (no DT)
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Both DT and no DT
Number of subjects: 251
Study: 28434387

Group type: EXPERIMENTAL
Intervention: bsIFX
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: bsIFX-ADA
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: bsIFX-ADA-VEDO
Number of subjects: 0
Study: 25385024

Group type: EXPERIMENTAL
Intervention: Mindfulness-Oriented Recovery Enhancement (MORE) for 8 weeks
Number of subjects: 29

Group type: COMPARATOR
Intervention: Support group control condition for 8 weeks
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Mindfulness-Oriented Recovery Enhancement (MORE)
Number of subjects: 29
Study: 24296479

Group type: EXPERIMENTAL
Intervention: rhBMP-2
Number of subjects: 197

Group type: COMPARATOR
Intervention: iliac crest autograft
Number of subjects: 197
Study: 21710405

Group type: EXPERIMENTAL
Intervention: Antipsychotic medication (various neuroleptic medications)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Neuroleptic wash-out (baseline)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 42
Study: 19526753

Group type: EXPERIMENTAL
Intervention: Compound Astragalus Recipe (CAR)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Prednisone (Control)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study: 16286908

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Future studies
Number of subjects: 0
Study: 12117080

Group type: EXPERIMENTAL
Intervention: Budesonide administered by Turbuhaler (DPI)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Budesonide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Budesonide therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pulmicort Respules (nebulized formulation)
Number of subjects: 0
Study: 10606369

Group type: EXPERIMENTAL
Intervention: Mab 3E10
Number of subjects: 9
Study: 8960734

Group type: EXPERIMENTAL
Intervention: Lee Silverman Voice Treatment (LSVT)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo (respiration) treatment
Number of subjects: 35
Study: 1762311

Group type: EXPERIMENTAL
Intervention: Acetate dialysate (Ac)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Acetate-free dialysate (Ac-free)
Number of subjects: 30
Study: 6122057

Group type: EXPERIMENTAL
Intervention: Oral ketoconazole
Number of subjects: 72

Group type: COMPARATOR
Intervention: Oral amphotericin B and nystatin
Number of subjects: 72
Study: 31703023

Group type: EXPERIMENTAL
Intervention: CLU (4 sets × (2 × 5) repetitions, 30‐s intraset rest, 90‐s interset rest)
Number of subjects: 8

Group type: COMPARATOR
Intervention: TRD (4 sets × 10 repetitions, 120‐s interset rest)
Number of subjects: 8
Study: 30980006

Group type: EXPERIMENTAL
Intervention: Smartphone application and movement sensor toothbrushing attachment
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control group (no smartphone device or toothbrush attachment)
Number of subjects: 108
Study: 27574900

Group type: EXPERIMENTAL
Intervention: Type I - suprapubic incision surgery without laparoscopic support
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Type II - suprapubic incision surgery with laparoscopic support but without CO2 inflation
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Type III - suprapubic incision surgery with laparoscopic support and CO2 inflation
Number of subjects: 43
Study: 25732163

Group type: EXPERIMENTAL
Intervention: Sunitinib 37.5 mg per day until progression
Number of subjects: 144

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Sunitinib after cross-over
Number of subjects: 144
Study: 25714213

Group type: EXPERIMENTAL
Intervention: Nebivolol
Number of subjects: 200

Group type: COMPARATOR
Intervention: Metoprolol
Number of subjects: 200
Study: 22865498

Group type: EXPERIMENTAL
Intervention: 0.85 g/day eicosapentaenoic acid (EPA) + docosahexaenoic acid (DHA) (low dose)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: 3.4 g/day EPA + DHA (high dose)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 19523539

Group type: EXPERIMENTAL
Intervention: Breastfeeding promotion interventions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Research staff assistance
Number of subjects: 0
Study: 17472824

Group type: EXPERIMENTAL
Intervention: Trial preparation of TMP/SMX 40/200 mg per 5-ml, oral suspension
Number of subjects: 24

Group type: COMPARATOR
Intervention: Reference preparation of TMP/SMX 40/200 mg per 5-ml, oral suspension
Number of subjects: 24
Study: 14962965

Group type: EXPERIMENTAL
Intervention: Immediate 6 week self management programme based on pool exercises and education (n = 84)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Waiting list control group (n = 80)
Number of subjects: 164
Study: 12691207

Group type: EXPERIMENTAL
Intervention: MDMA
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9590144

Group type: EXPERIMENTAL
Intervention: Granulocyte colony-stimulating factor (G-CSF) given as 200 microg/m2/d SC starting one day after HD C/T until neutrophil recovery
Number of subjects: 17

Group type: COMPARATOR
Intervention: High-dose cytarabine-containing chemotherapy (HD C/T) without G-CSF
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Granulocyte colony-stimulating factor (G-CSF)
Number of subjects: 17
Study: 7699487

Group type: EXPERIMENTAL
Intervention: Short Depression Screen (SDS) for Major Depressive Disorder (MDD)
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Short Depression Screen (SDS) for Depressive Disorders (MDD or Subsyndromal Depression - SubD)
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Hamilton Depression Rating Scale (HDRS) for MDD
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Hamilton Depression Rating Scale (HDRS) for SubD
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Functional impairment in patients with MDD or SubD
Number of subjects: 221
Study: 2713211

Group type: EXPERIMENTAL
Intervention: Bromocriptine (1.25 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Lisuride (0.1 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Terguride (0.25 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 279253

Group type: EXPERIMENTAL
Intervention: Think-With Instructions
Number of subjects: 66

Group type: COMPARATOR
Intervention: trance induction
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control
Number of subjects: 66
Study: 30716716

Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 27930609

Group type: EXPERIMENTAL
Intervention: Modified delivery of pre-ART counseling sessions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SMS reminders
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Point-of-care CD4 testing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Accelerated ART initiation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Noncash financial incentives
Number of subjects: 0
Study: 26022948

Group type: EXPERIMENTAL
Intervention: Saline pleural irrigation (three times per day for 3 days)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Saline pleural irrigation
Number of subjects: 35
Study: 24111983

Group type: EXPERIMENTAL
Intervention: Ziprasidone (40-160 mg/day)
Number of subjects: 283

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 283

Group type: EXPERIMENTAL
Intervention: Ziprasidone (OLE phase)
Number of subjects: 283

Group type: EXPERIMENTAL
Intervention: Ziprasidone (RCT and OLE phases)
Number of subjects: 283

Group type: COMPARATOR
Intervention: Ziprasidone and Placebo (RCT and OLE phases)
Number of subjects: 283
Study: 21239571

Group type: EXPERIMENTAL
Intervention: Phase-contrast radiography
Number of subjects: 37

Group type: COMPARATOR
Intervention: Conventional radiography
Number of subjects: 37
Study: 19725489

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 0
Study: 15772058

Group type: EXPERIMENTAL
Intervention: Power training (PWR; 4.73 rad/s)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Strength training (STR; 1.05 rad/s)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Both PWR and STR
Number of subjects: 17
Study: 12470401

Group type: EXPERIMENTAL
Intervention: High dose insulin with glucose, potassium and amino acids
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 25
Study: 9867064

Group type: EXPERIMENTAL
Intervention: Perindopril (PE)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 7543114

Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous infusion of GH (3.15 +/- 0.27 IU daily)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Daily subcutaneous injections of GH (3.15 +/- 0.27 IU daily)
Number of subjects: 13
Study: 2565517

Group type: EXPERIMENTAL
Intervention: Warmed platelet concentrates (incubated at 37 degrees C for 1 hour)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Unwarmed platelet concentrates (stored at room temperature)
Number of subjects: 15
Study: 330937

Group type: EXPERIMENTAL
Intervention: 1 mg methylproscillaridin (MP)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 31642088

Group type: EXPERIMENTAL
Intervention: Mobile application
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Booklet
Number of subjects: 360

Group type: COMPARATOR
Intervention: Placebo booklet
Number of subjects: 360
Study: 29706690

Group type: EXPERIMENTAL
Intervention: McGill stabilization exercises
Number of subjects: 34

Group type: COMPARATOR
Intervention: Conventional physiotherapy
Number of subjects: 34
Study: 28390207

Group type: EXPERIMENTAL
Intervention: NaF dentifrices containing 2.5% or 5% small particle size CSPS (4 µm)
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: NaF or SMFP dentifrices containing 5% CSPS (14 µm)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Regular fluoride dentifrice
Number of subjects: 134
Study: 25005784

Group type: EXPERIMENTAL
Intervention: Oral magnesium citrate 150 mg twice daily
Number of subjects: 3000

Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 3000
Study: 22799129

Group type: EXPERIMENTAL
Intervention: Full-mouth scaling and root planing (SRP) + ORN (test group)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Full-mouth scaling and root planing (SRP) + placebo (control group)
Number of subjects: 58
Study: 20408344

Group type: EXPERIMENTAL
Intervention: Fluticasone furoate (110 microg)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (200 microg)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Fluticasone furoate
Number of subjects: 360

Group type: COMPARATOR
Intervention: Fluticasone furoate and fluticasone propionate
Number of subjects: 360
Study: 18270828

Group type: EXPERIMENTAL
Intervention: Endoscopic ultrasound
Number of subjects: 19
Study: 15935263

Group type: EXPERIMENTAL
Intervention: OCD triggers from personal environment
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Disorder-irrelevant disgusting and fear-inducing material
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Photos of individual OCD-triggers
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Aversive picture conditions
Number of subjects: 10
Study: 12028392

Group type: EXPERIMENTAL
Intervention: Mind map study technique
Number of subjects: 50

Group type: COMPARATOR
Intervention: Self‐selected study technique
Number of subjects: 50
Study: 9807075

Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 27

Group type: COMPARATOR
Intervention: Acetaminophen with codeine
Number of subjects: 27
Study: 8584148

Group type: EXPERIMENTAL
Intervention: Ketamine (6 micrograms/kg/min after a bolus dose of 60 micrograms/kg)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Alfentanil (0.6 microgram/kg/min after a bolus dose of 7 micrograms/kg)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo (0.9% NaCl)
Number of subjects: 9
Study: 2518868

Group type: EXPERIMENTAL
Intervention: 10 mg cisapride q.d.s.
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo q.d.s.
Number of subjects: 12
Study: 1180299

Group type: EXPERIMENTAL
Intervention: Radical hysterectomy
Number of subjects: 119

Group type: COMPARATOR
Intervention: Radiotherapy
Number of subjects: 119
Study: 31735500

Group type: EXPERIMENTAL
Intervention: ChAdOx1 85A alone (low dose Starter Group, n=6)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: ChAdOx1 85A (Group A, n=12)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: ChAdOx1 85A prime - MVA85A boost (Group B, n=12)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: ChAdOx1 85A - ChAdOx1 85A prime - MVA85A boost (Group C, n=12)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: MVA85A
Number of subjects: 42
Study: 30980618

Group type: EXPERIMENTAL
Intervention: cream containing herbal mixture
Number of subjects: 90

Group type: COMPARATOR
Intervention: arbutin cream
Number of subjects: 90

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 90
Study: 27853882

Group type: EXPERIMENTAL
Intervention: hANP infusion
Number of subjects: 48
Study: 25885661

Group type: EXPERIMENTAL
Intervention: Intervention group with peer mentors, specific milestones, and access to a physician informaticist.
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group practices without support or guidance for registry implementation.
Number of subjects: 30
Study: 23434214

Group type: COMPARATOR
Intervention: Standard Intervention
Number of subjects: 80

Group type: COMPARATOR
Intervention: Insole
Number of subjects: 80

Group type: COMPARATOR
Intervention: Exercise
Number of subjects: 80

Group type: COMPARATOR
Intervention: Insole+Exercise
Number of subjects: 80
Study: 21157850

Group type: EXPERIMENTAL
Intervention: Services by a mental health professional in primary care or specialty settings
Number of subjects: 792

Group type: COMPARATOR
Intervention: Not applicable (control group not specified)
Number of subjects: 792
Study: 20030859

Group type: EXPERIMENTAL
Intervention: Western and Chinese medicine together (Group B)
Number of subjects: 340

Group type: COMPARATOR
Intervention: Western medicine only (Group A)
Number of subjects: 340
Study: 17846293

Group type: EXPERIMENTAL
Intervention: i.v. low dose nesiritide (0.005 microg/Kg/min for 24 hours)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 15118189

Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation (vitamin E, 500 mg/d; vitamin C, 1 g/d; beta-carotene, 30 mg/d)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo (lactose)
Number of subjects: 18
Study: 11697418

Group type: EXPERIMENTAL
Intervention: 7.5 mg retinol equivalent (RE) with childhood immunization
Number of subjects: 467

Group type: EXPERIMENTAL
Intervention: 15 mg retinol equivalent (RE) with childhood immunization
Number of subjects: 467

Group type: COMPARATOR
Intervention: Placebo with childhood immunization
Number of subjects: 467
Study: 9730072

Group type: EXPERIMENTAL
Intervention: Cornstarch-lubricated gloves
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Powder-free latex examination gloves
Number of subjects: 20

Group type: COMPARATOR
Intervention: Powdered gloves
Number of subjects: 20
Study: 8034780

Group type: EXPERIMENTAL
Intervention: Cross-tuft toothbrush
Number of subjects: 30

Group type: COMPARATOR
Intervention: Vertical-tuft toothbrush
Number of subjects: 30
Study: 30354969

Group type: EXPERIMENTAL
Intervention: Very early and more frequent mobilization in addition to usual stroke unit care
Number of subjects: 2104

Group type: COMPARATOR
Intervention: Usual stroke unit care
Number of subjects: 2104
Study: 27422025

Group type: EXPERIMENTAL
Intervention: Arthroscopic microfracture (MF)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Arthroscopic debridement (AD)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Physiotherapy
Number of subjects: 114
Study: 24984683

Group type: EXPERIMENTAL
Intervention: Low income
Number of subjects: 681

Group type: EXPERIMENTAL
Intervention: Moderate income
Number of subjects: 681

Group type: COMPARATOR
Intervention: Higher income
Number of subjects: 681
Study: 22882543

Group type: EXPERIMENTAL
Intervention: Salmeterol (50 µg twice a day, n = 30)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Fluticasone (125 µg twice a day, n = 10)
Number of subjects: 40
Study: 20729742

Group type: EXPERIMENTAL
Intervention: pegylated interferon‐α‐2a (180 μg/week) and ribavirin (1000‐1200 mg/day) for 48 weeks
Number of subjects: 575
Study: 18554989

Group type: EXPERIMENTAL
Intervention: Pulmonary rehabilitation
Number of subjects: 318

Group type: EXPERIMENTAL
Intervention: Self management
Number of subjects: 318

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 318

Group type: EXPERIMENTAL
Intervention: Economic evaluation
Number of subjects: 318
Study: 16869716

Group type: EXPERIMENTAL
Intervention: Phosphate depletion
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Phosphate loading
Number of subjects: 66
Study: 12540501

Group type: EXPERIMENTAL
Intervention: 200 mg of 4‐HPR/day for 5 years
Number of subjects: 1574

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 1574
Study: 10876750

Group type: EXPERIMENTAL
Intervention: Continuous irrigation with 40 micrograms/ml epirubicin solution for 20 hours after surgery
Number of subjects: 45

Group type: COMPARATOR
Intervention: Continuous irrigation with saline
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Continuous irrigation with 40 micrograms/ml epirubicin solution for 20 hours after surgery (for solitary tumors)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Continuous irrigation with saline (for solitary tumors)
Number of subjects: 45
Study: 9110838

Group type: EXPERIMENTAL
Intervention: Music intervention (listening to music of their own choosing)
Number of subjects: 0
Study: 8513773

Group type: EXPERIMENTAL
Intervention: Tyre pressure of 552 kPa
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Tyre pressure of 690 kPa
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Tyre pressure of 827 kPa
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Tyre pressure of 965 kPa
Number of subjects: 7
Study: 2942293

Group type: EXPERIMENTAL
Intervention: Kangbao Solution
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 67
Study: 31092278

Group type: EXPERIMENTAL
Intervention: Kilkari messages
Number of subjects: 5000

Group type: COMPARATOR
Intervention: Control group (no Kilkari messages)
Number of subjects: 5000
Study: 29734740

Group type: EXPERIMENTAL
Intervention: Mood Regulation Focused CBT (MR‐CBT)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 27
Study: 26956843

Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass surgery
Number of subjects: 137

Group type: COMPARATOR
Intervention: Lifestyle intervention
Number of subjects: 137
Study: 25416400

Group type: EXPERIMENTAL
Intervention: Treat-to-target (T2T) approach
Number of subjects: 530

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 530